The vector of anti-NY-ESO-1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human NY-ESO-1. The T cells are genetically modified through transduction with a retroviral vector expressing NY-ESO-1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-C188Z||Human anti-NY-ESO-1 T cell receptor (1G4), pCDTCR1|
|VP-TCR-C054||Lenti-NY-ESO-1 T cell receptor Viral Particle|
|VP-TCR-C053||Lenti-NY-ESO-1 Murinized T cell receptor Viral Particle|
|TCR-L080||Murinized (from Human) anti-CTAG1A (WITQCFLPVFLAQPPSGQRA) T Cell Receptor[Cysteine-modiﬁed], pMSGV1|
|TCR-L079||Human anti-CTAG1A (WITQCFLPVFLAQPPSGQRA) T Cell Receptor, pMSGV1|
|VP-TCR-C052||Lenti-NY-ESO-1 T cell receptor (Cysteine-modiﬁed) Viral Particle|
|TCR-L085||Human anti-CTAG1A (PVPGVLLKEFTVSGNILTIRLTA) T Cell Receptor, pLXSN|
|TCR-L078Z||Murinized anti-NY-ESO-1 (aa161-180) T cell receptor, pCDTCR1|
|VP-TCR-C047||Lenti-NY-ESO-1 T cell receptor (mESO C1) Viral Particle|
|TCR-L082||Mouse anti-CTAG1A T Cell Receptor, pMSGV1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved